AU2001276299A1 - Therapeutical use of sophora flavescens or sophora subprostrata extracts - Google Patents

Therapeutical use of sophora flavescens or sophora subprostrata extracts

Info

Publication number
AU2001276299A1
AU2001276299A1 AU2001276299A AU7629901A AU2001276299A1 AU 2001276299 A1 AU2001276299 A1 AU 2001276299A1 AU 2001276299 A AU2001276299 A AU 2001276299A AU 7629901 A AU7629901 A AU 7629901A AU 2001276299 A1 AU2001276299 A1 AU 2001276299A1
Authority
AU
Australia
Prior art keywords
sophora
extracts
subprostrata
flavescens
therapeutical use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276299A
Inventor
Clemens Erdelmeier
Egon Koch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Willmar Schwabe GmbH and Co KG
Original Assignee
Dr Willmar Schwabe GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe GmbH and Co KG filed Critical Dr Willmar Schwabe GmbH and Co KG
Publication of AU2001276299A1 publication Critical patent/AU2001276299A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to the use of extracts from Sophora flavescens or Sophora subprostrata< for the prophylaxis and therapy of pathological conditions that are caused by estrogen deficiency or by other dysregulations of the sex hormone metabolism, especially of the estrogen metabolism.
AU2001276299A 2000-06-29 2001-06-29 Therapeutical use of sophora flavescens or sophora subprostrata extracts Abandoned AU2001276299A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10031650 2000-06-29
DE10031650A DE10031650A1 (en) 2000-06-29 2000-06-29 Use of extracts from Sophora flavescens or Sophora subprostrata for the prophylaxis and therapy of disease states which are caused by a lack of estrogens or by other hormonal dysregulations
PCT/DE2001/002461 WO2002000237A1 (en) 2000-06-29 2001-06-29 Therapeutical use of sophora flavescens or sophora subprostrata extracts

Publications (1)

Publication Number Publication Date
AU2001276299A1 true AU2001276299A1 (en) 2002-01-08

Family

ID=7647186

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276299A Abandoned AU2001276299A1 (en) 2000-06-29 2001-06-29 Therapeutical use of sophora flavescens or sophora subprostrata extracts

Country Status (10)

Country Link
US (1) US20030190375A1 (en)
EP (1) EP1294389B1 (en)
JP (1) JP2004501202A (en)
CN (1) CN100455301C (en)
AT (1) ATE319465T1 (en)
AU (1) AU2001276299A1 (en)
DE (2) DE10031650A1 (en)
ES (1) ES2257423T3 (en)
MX (1) MXPA02012528A (en)
WO (1) WO2002000237A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1360959A1 (en) * 2002-05-10 2003-11-12 Schering Aktiengesellschaft Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
US7384657B2 (en) * 2004-10-14 2008-06-10 Jeffrey Young Composition of natural herb extract for treating cardiovascular disease and its method of preparation thereof
KR101086037B1 (en) * 2004-10-27 2011-11-22 에스케이케미칼주식회사 Preventive and curative extracts from Sophorae Radix for respiratory organ disease
JP2006146490A (en) * 2004-11-18 2006-06-08 Ricoh Co Ltd Print controller and print control program
WO2006057893A2 (en) * 2004-11-22 2006-06-01 Edward Larry Mccleary Composition, delivery system and method for promoting healthy sexual function
CA2588180A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
CN101040899B (en) * 2006-03-20 2013-06-19 周亚伟 Antineoplastic Chinese traditional compound and the preparation and the method for producing the same
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
AU2008285325A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of Ligustrum lucidum and uses thereof
EP2203178A4 (en) * 2007-09-07 2012-03-21 Bionovo Inc Estrogenic extracts of pueraria lobata willd, ohwi of the leguminosae family and uses thereof
EP2194998A4 (en) * 2007-09-07 2012-03-21 Bionovo Inc Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof
US9155770B2 (en) * 2007-09-07 2015-10-13 Bionovo, Inc. Estrogenic extracts of Scuttelaria barbata D. don of the labiatae family and uses thereof
US20090068298A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. ESTROGENIC EXTRACTS OF Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family AND USES THEREOF
AU2008326429A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
CA2706326A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
AU2008329902A1 (en) * 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata D. Don
WO2009067550A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
EP2276480A4 (en) * 2008-04-14 2011-08-10 Bionovo Inc Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
CA2723403A1 (en) * 2008-05-06 2009-11-12 Bionovo, Inc. Estrogenic extracts for use in treating vaginal and vulvar atrophy
CA2726982A1 (en) * 2008-06-05 2009-12-10 Bionovo, Inc. Method of quantification of multiple bioactives from botanical compositions
CA2727018A1 (en) * 2008-06-06 2009-12-10 Bionovo, Inc. Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
US20090312274A1 (en) * 2008-06-13 2009-12-17 Bionovo, Inc. Nyasol and Analogs Thereof for the Treatment of Estrogen Receptor Beta-Mediated Diseases
WO2010028187A2 (en) * 2008-09-03 2010-03-11 Bionovo, Inc. Methods and compositions for the treatment of cancer
EP2424555A4 (en) * 2009-04-28 2013-02-20 Bionovo Inc Method of reducing fat accumulation and inducing weight loss
KR101345653B1 (en) * 2010-01-11 2013-12-27 주식회사 고려비엔피 Compositions Comprising Sophora Subprostrata Extracts for Inhibiting the Activity of Acetylcholinesterase
KR101334887B1 (en) 2011-10-31 2013-11-29 한국과학기술연구원 Composition for preventing and/or alleviating hangover comprising extracts of Sophora flavescens
CN103301190B (en) * 2012-06-19 2015-10-14 中国医学科学院药用植物研究所 The extract of Radix Sophorae Tonkinensis and application thereof
CN103006761B (en) * 2012-12-06 2015-02-18 江苏大学 Extract of antineoplastic active components in vietnamese sophora root, and preparation method and application thereof
CN110302339A (en) * 2019-08-12 2019-10-08 赵君 A kind of pure Chinese medicine paste preventing women with breast cancer
DE102021124067A1 (en) 2021-09-17 2023-03-23 Zongzhi Detection Tech Development Ltd Composition of Traditional Chinese Medicine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01230525A (en) * 1988-03-10 1989-09-14 Nitto Denko Corp Production of antiulcer agent

Also Published As

Publication number Publication date
MXPA02012528A (en) 2004-05-17
EP1294389A1 (en) 2003-03-26
JP2004501202A (en) 2004-01-15
ATE319465T1 (en) 2006-03-15
WO2002000237A1 (en) 2002-01-03
CN1438893A (en) 2003-08-27
DE50109164D1 (en) 2006-05-04
EP1294389B1 (en) 2006-03-08
DE10031650A1 (en) 2002-01-17
ES2257423T3 (en) 2006-08-01
CN100455301C (en) 2009-01-28
US20030190375A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
AU2001276299A1 (en) Therapeutical use of sophora flavescens or sophora subprostrata extracts
IL258880A (en) Diarylhydantoin compounds
PT1187632E (en) Treatment with anti-erbb2 antibodies
AU2000233235A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
HK1067128A1 (en) Beta-carbolin derivatives as ptp-inhibitors
TW200509937A (en) Novel compounds and their use in therapy
WO2004028454A3 (en) 1, 3, 5-triazines for treatment of viral diseases
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
AU2001275659A1 (en) Extracts from sophora species, method for producing the same and their use
EP1410796A3 (en) New therapeutic uses for potassium channel openers
SG167670A1 (en) Aminocyclohexyl ether compounds and uses thereof
AU2002324451A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
AU2002358390A1 (en) Novel compounds
WO2001017543A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
MXPA03011546A (en) New use.
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
HK1040983A1 (en) Quinones for treatment of diseases.
AU2003290592A1 (en) Antitumor benzoylsulfonamides
EP1105407A4 (en) Aminosterol compounds and uses thereof
EP1441724B8 (en) Methods of increasing endogenous testosterone levels
WO2003105753A3 (en) Targeted enzymes and methods of making and using targeted enzymes.
MXPA02001204A (en) Calcilytic compounds.
MXPA03008946A (en) Methods of synthesizing phenol-containing compounds.
WO2002020000A3 (en) Combined estrogen blockade of the breast with exemestane and raloxifene
AU2002251788A1 (en) Novel compounds and uses thereof